Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 113.20
-0.20 (-0.18%)
Oct 23, 2026, 1:44 PM IDT
Evogene Market Cap
Evogene has a market cap or net worth of 17.89 million as of October 23, 2026. It is the 44,270th most valuable company in the world and the 471st biggest in Israel. Its market cap has decreased by 51.36% in one year.
Market Cap
17.89M
Enterprise Value
23.38M
Revenue
4.94M
Global Rank
Country Rank
#471 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 17.89M, a decrease of -84.19%. That is a compound annual growth rate of -9.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 17.89M | -31.73% |
| Dec 31, 2025 | 26.20M | -44.67% |
| Dec 31, 2024 | 47.35M | -68.75% |
| Dec 31, 2023 | 151.55M | 64.52% |
| Dec 29, 2022 | 92.12M | -58.37% |
| Dec 30, 2021 | 221.26M | -59.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 206.76M |
| Matricelf | 79.46M |
| BioLineRx | 35.84M |
| Clal Biotechnology Industries | 35.13M |
| Purple Biotech | 32.42M |
| BioLight Life Sciences | 27.19M |
| XTL Biopharmaceuticals | 19.87M |
| Can-Fite BioPharma | 18.47M |